Dr. Andrew Barnes and Dr. Caroline Cobb have been awarded a R03 funded by the National Institute on Drug Abuse and FDA Center for Tobacco Products
September 15, 2016
This two-year grant will systematically evaluate the effect of four flavors of Black and Mild cigars on measures of abuse liability in young adult conventional tobacco cigarette (CTC) smokers.
More of the logic behind the grant:
Tobacco use contributes to nearly half a million deaths in the United States annually. To reduce this death toll, the Food and Drug Administration (FDA) was granted regulatory authority over tobacco in 2009. This authority was limited with respect to cigars, which are increasingly popular. The availability of cigar flavors, among other characteristics, has been linked to increased sales and consumption, with the largest increases among youth/young adults and certain racial/ethnic minorities. No studies exist quantifying the effect of cigar flavors on abuse liability—the degree to which a psychoactive drug or formulation would be used for nonmedical purposes and that abuse would lead to dependence. Such evidence is essential to reducing cigar smoking among youth/young adults, who have a high risk of experimentation and relevance to FDA priorities. The current study aims to address this critical evidence gap by systematically examining the effect of four flavors of Black & Mild (B&M), the most popular cigar brand on measures of abuse liability in young adult conventional tobacco cigarette (CTC) smokers.